| MR编号 | NL/H/2881/004 |
|---|
| 药品名称 | Levobupivacaïne Fresenius Kabi 5 mg/ml |
|---|
| 活性成分 | - Levobupivacaine hydrochloride 5.0 mg/ml
|
|---|
| 剂型 | solution for injection or infusion |
|---|
| 上市许可持有人 | Fresenius Kabi Deutschland GmbH
Borkenberg 14
61440 Oberursel |
|---|
| 参考成员国 - 产品名称 | Netherlands (NL) Levobupivacaïne Fresenius Kabi 5 mg/ml, oplossing voor injectie/infusie |
|---|
| 互认成员国 - 产品名称 | - Belgium (BE)
Levobupivacaïne Fresenius Kabi 5mg/ml oplossing voor injectie/infusie - United Kingdom (Northern Ireland) (XI)
- Ireland (IE)
- France (FR)
- Spain (ES)
- Portugal (PT)
- Italy (IT)
- Czechia (CZ)
Levobupivacain Kabi 5 mg/ml - Slovakia (SK)
- Slovenia (SI)
Levobupivakain Kabi 5,0 mg/ml raztopina za injiciranje/infundiranje - Croatia (HR)
Levobupivakain Kabi 5 mg/ml otopina za injekciju/infuziju
|
|---|
| 许可日期 | 2014/04/21 |
|---|
| 最近更新日期 | 2024/11/04 |
|---|
| 药物ATC编码 | | 申请类型 | - TypeLevel1：Abridged
- TypeLevel2：Additional Strength/Form
- TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
- TypeLevel4：Chemical Substance
- TypeLevel5：Prescription Only
|
|---|
| 附件文件下载 | |
|---|
| 市场状态 | Positive |
|---|
|
|---|